- AZD5363
-
- $2.00 / 1kg
-
2019-07-06
- CAS:1143532-39-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
| | AZD5363 Basic information |
| Product Name: | AZD5363 | | Synonyms: | AZD5356;AZD5363;4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide;4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide AZD5363;AZD 5363 dihydrochloride;AZD5363;AZD-5363;AZD 5363;(S)-4-Amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidi;AZD5363, 99%, a potent pan-AKT kinase inhibitor | | CAS: | 1143532-39-1 | | MF: | C21H25ClN6O2 | | MW: | 428.92 | | EINECS: | | | Product Categories: | Akt;mTOR;PI3K;PI3K/Akt/mTOR;Inhibitors | | Mol File: | 1143532-39-1.mol |  |
| | AZD5363 Chemical Properties |
| Melting point | 161-164°C | | density | 1.381 | | storage temp. | Refrigerator | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 13.93±0.50(Predicted) | | form | Solid | | color | Off-White to Pale Beige |
| | AZD5363 Usage And Synthesis |
| Uses | AZD5363 is used in inhibiting the proliferation of certain tumor cell lines. | | Biological Activity | azd5363 is a novel, potent phosphoinositide 3-kinase (pi3k)/akt pathway inhibitor with ic50 value of ~200nm. [1]azd5363 is proved to inhibit castrate resistant prostate cancer (crpc) progression. clusterin (clu) and autophagy will be induced which may work as cytoprotective responses which can affect the downstream pi3k/akt signaling. [2] azd5363 inhibits the growth of a lot of human tumor cells in a dose dependent manner. the mode of action could be monotherapy as well as in combination with her2 inhibitors in breast cancer models. [3] it is suggested to induce cell apoptosis by measuring the expression of parp cleavage, the activity of caspase 3, et al. [1]most importantly, azd5363 can target the pi3k/akt-pathway in vivo significantly, thus reducing the serum psa-levels and tumor volume, finally, it could postpone the progression to crpc.[1] | | target | Akt | | storage | Store at -20°C | | references | [1] thomas c, crafter c, davies b, zoubeidi a, gleave me. azd5363, a novel akt inhibitor, delays prostate cancer progression. the journal of urology. may 2011. 185(4s): e292-293.
[2] kumano m, zhang f, shiota m, crafter c, davies b, zoubeidi a, gleave m. clusterin knockdown enhances antitumor activity of a novel akt inhibitor, azd5363, through inhibition of autophagy in prostate cancer. the journal of urology. may 21 2012. e392.
[3] davies br, greenwood h, dudley p, et al. preclinical pharmacology of azd5363, an inhibitor of akt: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background. mol. cancer ther. arp 2012. 11: 873. |
| | AZD5363 Preparation Products And Raw materials |
|